Delivery Order SPE2DE24D0013-SPE2D626F21S5
- Not listed
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $10,200.00 by the Defense Logistics Agency Medical Supply Chain on December 10, 2025. The firm fixed-price delivery order, with an ultimate completion date of December 17, 2025, is designated as XPRS4PLEX-10 and carries no set-aside designation. This delivery order falls under Cepheid's broader contracting relationship with federal healthcare agencies, where...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $40,946.80 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 9, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, pertains to molecular diagnostic reagents and test cartridges for detecting COVID-19, influenza, and respiratory syncytial virus using Cepheid's GeneXpert diagnostic platform. The contract carries no...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $6,800 under a firm fixed-price contract by the Defense Logistics Agency Medical Supply Chain on December 1, 2025, with an ultimate completion date of December 8, 2025. This delivery order, designated XPRS4PLEX-10, was issued with no set-aside designation and calls for the supply of diagnostic reagents and test kits for Cepheid's GeneXpert diagnostic platform,...
- Cepheid Inc., a leading molecular diagnostics manufacturer headquartered in Sunnyvale, California, was awarded a delivery order valued at $5,099.70 by the Defense Logistics Agency Medical Supply Chain on November 12, 2025, with an ultimate completion date of November 19, 2025. This firm fixed-price delivery order, designated XPRS4PLEX-10, represents procurement of diagnostic reagents and test kits—specifically XPRS4PLEX-10 cartridges designed for the GeneXpert diagnostic platform. The contract...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $1,382.52 by the Defense Logistics Agency Medical Supply Chain on November 12, 2025, with an ultimate completion date of November 19, 2025. This firm fixed-price delivery order, designated XPRSMVP-10, carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. As a leading federal supplier of advanced molecular diagnostic systems and reagents, Cepheid has...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $27,650.40 by the Defense Logistics Agency Medical Supply Chain on November 13, 2025. This firm fixed-price delivery order, designated XPRSMVP-10 with completion targeted for November 20, 2025, represents a procurement of diagnostic testing supplies and reagents under an existing indefinite delivery contract vehicle. The award carries no set-aside designation,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $13,709.36 by the Defense Logistics Agency Medical Supply Chain on November 13, 2025, with an ultimate completion date of November 20, 2025. This firm fixed-price delivery order, identified as XPRSMVP-10, carries no set-aside designation and represents a continuation of Cepheid's substantial role as a primary federal supplier of diagnostic solutions. The...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems and reagents, was awarded a delivery order valued at $5,236.00 by the Defense Logistics Agency Medical Supply Chain on October 27, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is for diagnostic testing supplies supporting detection of COVID-19, influenza, and respiratory syncytial virus, with a firm fixed-price structure and ultimate completion date of November 10, 2025. The contract...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $3,400 under contract XPRS4PLEX-10 by the Defense Logistics Agency's Medical Supply Chain on December 3, 2025, with an ultimate completion date of December 10, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a procurement of diagnostic testing supplies from Cepheid, a leading manufacturer of molecular diagnostic systems and reagents specializing in...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $2,720 on October 29, 2025, by the Defense Logistics Agency Medical Supply Chain for diagnostic testing supplies and reagents. The delivery order, designated as XPRS4PLEX-10, is structured as a firm fixed-price contract with an ultimate completion date of November 5, 2025, and no set-aside designation. This award falls under Cepheid's broader contracting...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F21S5Delivery Order
Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $8,160 delivery order (4570311575 | XPRS4PLEX-10) by the Defense Logistics Agency's Medical Supply Chain on December 15, 2025, with an ultimate completion date of December 22, 2025. This firm fixed-price delivery order, which carries no set-aside designation, falls under a larger single-award Indefinite Delivery Contract valued at $6.7 million with the Department of Veterans Affairs' VISN 17 that extends through December 28, 2029. The delivery order is for diagnostic reagents and test kits, specifically XPRS4PLEX-10 cartridges designed for Cepheid's GeneXpert diagnostic platform, which is used to detect multiple respiratory pathogens across VA medical center laboratories. Cepheid has positioned itself as a primary federal supplier of molecular diagnostic solutions across multiple federal healthcare agencies, including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and U.S. Coast Guard. The company's core competencies include providing rapid molecular diagnostic testing for COVID-19, influenza, respiratory syncytial virus, MRSA, tuberculosis, and other infectious diseases. Beyond routine federal procurement, Cepheid engages in research collaboration and international capacity-building, including recent sub-grant work with Rutgers University on point-of-care detection of drug-resistant tuberculosis and technical support to Uganda for adopting advanced drug susceptibility testing methods.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.2k | 12/14/25 |